Harnessing Two-Dimensional Nanomaterials for Diagnosis and Therapy in Neurodegenerative Diseases: Advances, Challenges and Prospects

Samir Kumar Beura,Abhishek Ramachandra Panigrahi,Pooja Yadav,Irene Palacio,Elena Casero,Carmen Quintana,Jyoti Singh,Manoj Kumar Singh,Jose A. Martín Gago,Sunil Kumar Singh
DOI: https://doi.org/10.1016/j.arr.2024.102205
IF: 11.788
2024-01-24
Ageing Research Reviews
Abstract:Neurodegenerative diseases (NDDs) are specific brain disorders characterized by the progressive deterioration of cognitive functions, particularly memory, thinking, and social abilities. Current conventional therapeutic options for NDDs are limited in addressing underlying causes, delivering drugs to specific neuronal targets, and promoting tissue repair following brain injury. Due to the paucity of plausible theranostic options for NDDs, nanobiotechnology has emerged as a promising field, offering an interdisciplinary approach to create nanomaterials with high diagnostic and therapeutic efficacy for these diseases. Recently, two-dimensional nanomaterials (2D-NMs) have gained significant attention in biomedical and pharmaceutical applications due to their precise drug-loading capabilities, controlled release mechanisms, enhanced stability, improved biodegradability, and reduced cell toxicity. Although various studies have explored the diagnostic and therapeutic potential of different nanomaterials in NDDs, there is a lack of comprehensive reviews addressing the theranostic applications of 2D-NMs in these neuronal disorders. Therefore, this concise review aims to provide a state-of-the-art overview of the need for these ultrathin 2D-NMs and their potential applications in theranostics, including biosensing and bioimaging, targeted drug delivery, tissue engineering, and regenerative medicine for NDDs.
cell biology,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?